- Home
- OABI vs OGI Comparison
OABI vs OGI Comparison
Compare OABI & OGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OABI
- OGI
- Stock Information
- Founded
- OABI 2012
- OGI 2013
- Country
- OABI United States
- OGI Canada
- Employees
- OABI N/A
- OGI N/A
- Industry
- OABI Biotechnology: Pharmaceutical Preparations
- OGI Biotechnology: Pharmaceutical Preparations
- Sector
- OABI Health Care
- OGI Health Care
- Exchange
- OABI Nasdaq
- OGI Nasdaq
- Market Cap
- OABI 228.9M
- OGI 231.9M
- IPO Year
- OABI N/A
- OGI N/A
- Fundamental
- Price
- OABI $1.64
- OGI $1.78
- Analyst Decision
- OABI Strong Buy
- OGI
- Analyst Count
- OABI 3
- OGI 0
- Target Price
- OABI $6.67
- OGI N/A
- AVG Volume (30 Days)
- OABI 435.2K
- OGI 720.5K
- Earning Date
- OABI 11-11-2025
- OGI 08-13-2025
- Dividend Yield
- OABI N/A
- OGI N/A
- EPS Growth
- OABI N/A
- OGI N/A
- EPS
- OABI N/A
- OGI 0.05
- Revenue
- OABI $23,027,000.00
- OGI $164,107,753.00
- Revenue This Year
- OABI N/A
- OGI $58.15
- Revenue Next Year
- OABI $44.99
- OGI $14.60
- P/E Ratio
- OABI N/A
- OGI $34.64
- Revenue Growth
- OABI 6.05
- OGI 50.01
- 52 Week Low
- OABI $1.22
- OGI $0.85
- 52 Week High
- OABI $4.87
- OGI $2.00
- Technical
- Relative Strength Index (RSI)
- OABI 45.25
- OGI 68.21
- Support Level
- OABI $1.54
- OGI $1.56
- Resistance Level
- OABI $1.68
- OGI $1.70
- Average True Range (ATR)
- OABI 0.08
- OGI 0.07
- MACD
- OABI 0.01
- OGI 0.01
- Stochastic Oscillator
- OABI 62.79
- OGI 89.58
About OABI OmniAb Inc.
OmniAb Inc offers therapeutic antibody discovery technologies. It focuses on enabling the rapid development of therapeutics by pushing the frontiers of drug discovery technologies. Its technology platform is designed to enable the efficient discovery of high-quality, fully human antibodies for a wide range of diseases. The heart of the OmniAb technology platform is the Biological Intelligence of its proprietary transgenic animals, including OmniRat, OmniMouse, and OmniChicken, that have been genetically modified to generate antibodies with human sequences which are naturally optimized through in vivo affinity maturation.
About OGI Organigram Holdings Inc.
Organigram Global Inc is a licensed cultivator of cannabis and manufacturer of cannabis-derived goods in Canada. It is is focused on producing high-quality cannabis for adult recreational consumers. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT and DEBUNK. Organigram operates facilities in Moncton, New Brunswick and Lac-Superieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba.